The Tyrosine Kinase Csk Dimerizes through Its SH3 Domain by Levinson, Nicholas M. et al.
The Tyrosine Kinase Csk Dimerizes through Its SH3
Domain
Nicholas M. Levinson
1¤, Patrick R. Visperas
1, John Kuriyan
1,2,3,4,5*
1Department of Molecular and Cell Biology, University of California, Berkeley, California, United States of America, 2Department of Chemistry, University of California,
Berkeley, California, United States of America, 3California Institute for Quantitative Biosciences, University of California, Berkeley, California, United States of America,
4Howard Hughes Medical Institute, University of California, Berkeley, California, United States of America, 5Physical Biosciences Division, Lawrence Berkeley National
Laboratory, Berkeley, California, United States of America
Abstract
The Src family kinases possess two sites of tyrosine phosphorylation that are critical to the regulation of kinase activity.
Autophosphorylation on an activation loop tyrosine residue (Tyr 416 in commonly used chicken c-Src numbering) increases
catalytic activity, while phosphorylation of a C-terminal tyrosine (Tyr 527 in c-Src) inhibits activity. The latter modification is
achieved by the tyrosine kinase Csk (C-terminal Src Kinase), but the complete inactivation of the Src family kinases also
requires the dephosphorylation of the activation loop tyrosine. The SH3 domain of Csk recruits the tyrosine phosphatase
PEP, allowing for the coordinated inhibition of Src family kinase activity. We have discovered that Csk forms homodimers
through interactions mediated by the SH3 domain in a manner that buries the recognition surface for SH3 ligands. The
formation of this dimer would therefore block the recruitment of tyrosine phosphatases and may have important
implications for the regulation of Src kinase activity.
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Introduction
Members of the Src family of protein tyrosine kinases, such as c-
Src, Lck, Fyn and Hck, are key players in many signalling
pathways that regulate cell growth, proliferation and motility [1].
Src kinase activity is tightly controlled through phosphorylation at
two regulatory sites, Tyr 416 and Tyr 527 (chicken c-Src
numbering) [2]. Autophosphorylation of the Src family kinases
on Tyr 416, located within a central regulatory element in the
kinase domain known as the activation loop, increases activity by
stabilizing the kinase domain in a conformation that promotes
catalysis [3]. In contrast, the phosphorylation of Tyr 527 in the C-
terminal tail of the Src family kinases by Csk (C-terminal Src
Kinase) results in the intramolecular engagement of the tail by the
Src Homology 2 (SH2) domain and the concomitant docking of
the Src Homology 3 (SH3) domain onto the SH2-kinase linker,
which together stabilize the kinase domain in an inactive
conformation [4,5,6,7,8]. Full inactivation of the Src family
kinases consequently requires both dephosphorylation of the
activation loop and phosphorylation of the C-terminal tail [9].
The kinase domain of Csk is responsible for the recognition of
the Src family kinases as its specific substrates, resulting in
phosphorylation of the C-terminal tail [10]. The ability of Csk to
regulate Src kinase activity in vivo also depends on both the SH2
and SH3 domains of Csk [11,12]. Unlike the Src family kinases,
Csk is not constitutively membrane-localized, and the SH2
domain is required for the recruitment of Csk to the plasma
membrane. Several different proteins have been shown to recruit
Csk through its SH2 domain, including paxillin [12] and the
transmembrane adapter protein Cbp (Csk-binding protein) [13].
The SH3 domain of Csk interacts with several tyrosine
phosphatases [14,15]. In T-cells, Csk associates with the tyrosine
phosphatase PEP, which dephosphorylates the activation loop of
the Src family kinase Lck [16]. The association of Csk and PEP
provides for a coordinated downregulation of Lck through
simultaneous phosphorylation of the C-terminus and dephosphor-
ylation of the activation loop. Csk has also been reported to
associate with the widely expressed tyrosine phosphatase PTP-
PEST in non-haematopoietic cells [15], suggesting that such a
coordinated mechanism may be widespread.
Pursuing the observation that Csk is dimeric at high protein
concentration (i.e., ,1 mg/ml or greater) in vitro [17], we have
discovered that Csk dimerizes in a manner that is incompatible
with the binding of ligands to the SH3 domain. By interfering with
the recruitment of tyrosine phosphatases, Csk dimerization could
serve to modulate the degree of activation loop phosphorylation
and activity of the Src family kinases.
Results and Discussion
Dimerization of Csk Requires the SH3 Domain
Csk protein is dimeric in solution, as indicated by analytical
ultra-centrifugation and gel filtration chromatography [17], but
the molecular nature of this dimer interaction is unknown. We
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of Csk (see figure 1), and found that while the full-length protein
(CskFL) migrates as a dimer by size exclusion, the removal of the
SH3 domain (CskSH2KD) or the SH3 and SH2 domains (CskKD)
resulted in proteins that no longer appear to dimerize and instead
elute as apparent monomers by gel filtration (figure 1). This
suggests that the SH3 domain of Csk is involved in the dimer
interface.
The SH3 Domain Mediates Dimerization of Csk
Analysis of the crystal packing interactions in the crystal
structure of full-length Csk [17] reveals an interaction that is
consistent with the requirement of the SH3 domain for
dimerization. The crystal structure contains 6 molecules of Csk
in the asymmetric unit, and pairs of SH3 domains form symmetric
interactions consistent with dimer formation. The interaction
buries a total of 946 A ˚ 2 of surface area between the two domains
and includes several hydrophobic contacts (figure 2). Despite the
fact that the six molecules of Csk in the asymmetric unit of this
structure are in somewhat different conformations, the SH3
domains of each molecule participate in identical dimer
interactions with adjacent molecules in the crystal lattice.
Intriguingly the same interaction is also observed in the crystal
structure of the isolated SH3 domain of Csk [18], suggesting that
this interaction might be physiologically relevant.
We mutated the surface of the SH3 domain of Csk that
mediates the putative dimer interaction extensively, and assessed
the ability of the mutant proteins to dimerize by size exclusion
chromatography (figure 2). Of the six mutant proteins tested, five
migrate as monomers, while the protein bearing the Asn 63 Ala
mutation migrates mostly as a dimer, with a small shoulder
corresponding to a monomer species. This is consistent with the
observation from the structure that Asn 63 makes only very weak
interactions in the interface (i.e., it does not form tight hydrogen
bonds with neighboring residues). These results indicate that the
dimers of Csk observed in solution rely on the SH3–SH3 interface
seen in the crystal structures of full-length Csk and the isolated
SH3 domain.
The Csk Dimer Is Incompatible with the Binding of
Ligands to the SH3 Domain
SH3 domains bind to peptides containing PXXP sequences that
readily form polyproline type II helices [19,20,21]. The SH3
domain of Csk binds to a polyproline motif (referred to as 3BP1,
for SH3 binding peptide 1) in the C-terminus of the protein
tyrosine phosphatase PEP [22], and the recruitment of PEP and
Csk to the membrane is required for inhibition of T-cell signaling
[16]. The 3BP1 motif of PEP binds to Csk with an unusually high
affinity compared to most SH3-peptide interactions, and the high
affinity interaction depends on a hydrophobic motif C-terminal to
the polyproline motif [22]. The solution structure of the SH3
domain of Csk in complex with a peptide comprising the 3BP1
motif demonstrated that in addition to the canonical polyproline
helix-SH3 interaction, the hydrophobic residues in the 3BP1 motif
also form interactions with the SH3 domain [23].
In the Csk SH3-SH3 homodimer the ligand binding surface on
both SH3 domains is occluded. This is demonstrated by a
comparison between the Csk residues involved in the SH3-SH3
dimer interface with those involved in binding the 3BP1 peptide
(figure 3). It is therefore expected that the formation of the SH3-
SH3 dimer would prevent the binding of the 3BP1 peptide and
vice versa. This is consistent with the observation that the addition
of the 3BP1 peptide to the isolated SH3 domain prevents
oligomerization of the SH3 domain [23]. Interestingly, the
secondary binding site for the hydrophobic residues of 3BP1 is
not occluded by the SH3-SH3 dimer (figure 3). It is possible that
PEP might still be able to interact weakly with a Csk dimer
through this secondary binding site, although the binding of other
phosphatases, such as PTP-PEST, to the Csk SH3 domain would
be completely blocked by the formation of the dimer.
A Speculative Model for the Functional Role of the Csk
Homodimer
The recruitment of both Csk and PEP to the plasma membrane
is critical for the inhibition of T-cell signaling [16]. The
observation that the Csk homodimer should interfere with the
binding of the PEP phosphatase to the SH3 domain suggests that
the two interactions may compete in cells. The dimerization of Csk
could therefore have a profound influence on the recruitment of
phosphatases to sites of Src kinase activity, with important
implications for the regulation of the Src kinases.
The 3BP1 element of PEP interacts with the SH3 domain of
Csk with a KD value of ,800 nM [23]. The affinity of the SH3-
SH3 interaction is unknown, but our gel filtration data indicate
that the dimer is formed at 20 mM. The question therefore
remains whether the SH3-SH3 interaction can effectively
compete with the relatively high affinity SH3-PEP interaction.
The recruitment of proteins to the cell membrane may increase
their effective concentration by as much as 1000-fold [24],
allowing interactions that are weak in solution to play a significant
role [25]. The phosphorylated cytoplasmic domain of Cbp is
known to form oligomers that bind multiple molecules of Csk [26],
potentially providing a platform on which Csk molecules are
Figure 1. The SH3 domain of Csk is required for dimerization.
A) The constructs used in this paper. B) The results of size exclusion
chromatography performed with the constructs shown in A. The elution
volumes of molecular weight standards are indicated by black arrows.
doi:10.1371/journal.pone.0007683.g001
Csk Dimerization
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formation of dimers, resulting in the displacement of the
phosphatase, and allowing for the activation of Lck through
autophosphorylation. In this light it would be interesting to see
how mutations that disrupt the Csk SH3-SH3 dimer interface
affect signaling in cells.
Figure 2. The Csk SH3-SH3 dimer. A) A representative SH3-SH3 dimer from the crystal structure of full-length Csk (PDB code: 1K9A). Residues in
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Expression and Purification of Csk Constructs
The constructs of human Csk, CskFL (residues 1–450),
CskSH2KD (residues 68–450) and CskKD (residues 187–450) were
expressed in bacteria and purified as described [10]. The SH3
domain mutations were prepared using the Quikchange protocol
(Statagene) and verified by DNA sequencing.
Gel Filtration Chromatography
Purified Csk proteins were subjected to analytical gel filtration
using a Superdex S200 column (GE Healthcare) or SMART S200
column (GE Healthcare). Column calibration was performed
using molecular weight standards (Ferritin, Catalase, GST,
Ribonuclease).
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